Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Gandhi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Indian Prosthodontic Society|December 13, 2022
Comparative evaluation of tensile strength, tear strength, color stability and hardness of conventional and 1% trisnorbornenylisobutyl polyhedralsilsesquioxane modified room temperature vulcanizing maxillofacial silicone after a six month artificial aging periodDrashti Sunil Gandhi, Rajesh Sethuraman
HCA Healthcare Journal of Medicine|July 12, 2023
Adenocarcinoma of the Transverse Colon Presenting as Anterior Abdominal Wall AbscessJenn Klein, Nima Avin, Sunil Gandhi
Research Square|April 24, 2023
Pattern Completion and Rate Remapping in Retrosplenial CortexZaneta Navratilova, Dhruba Banerjee, Fjolla Muqolli, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentNathaniel Guanzon, Yessenia Gallegos, Chase Redd, et al.
Journal of Hematology & Oncology|November 30, 2012
A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomideEunice S Wang, Roger M Lyons, Richard A Larson, et al.
Elife|February 22, 2022
TREM2 regulates purinergic receptor-mediated calcium signaling and motility in human iPSC-derived microgliaAmit Jairaman, Amanda McQuade, Alberto Granzotto, et al.
Annals of Clinical and Translational Neurology|January 12, 2026
Fluid and Neuroimaging Biomarkers in Microgliopathy Colony-Stimulating Factor-1 Receptor-Related DisordersTomasz Chmiela, Madison Reeves, Karen Jansen-West, et al.
Cancer Immunology, Immunotherapy : CII|March 2, 2024
A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancerGerald S Falchook, James Reeves, Sunil Gandhi, et al.
Neuron|June 19, 2024
Therapeutic potential of human microglia transplantation in a chimeric model of CSF1R-related leukoencephalopathyJean Paul Chadarevian, Jonathan Hasselmann, Alina Lahian, et al.
JAMA Oncology|September 1, 2022
Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical TrialNizar M Tannir, Neeraj Agarwal, Camillo Porta, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Indian Prosthodontic Society|December 13, 2022
Comparative evaluation of tensile strength, tear strength, color stability and hardness of conventional and 1% trisnorbornenylisobutyl polyhedralsilsesquioxane modified room temperature vulcanizing maxillofacial silicone after a six month artificial aging periodDrashti Sunil Gandhi, Rajesh Sethuraman
HCA Healthcare Journal of Medicine|July 12, 2023
Adenocarcinoma of the Transverse Colon Presenting as Anterior Abdominal Wall AbscessJenn Klein, Nima Avin, Sunil Gandhi
Research Square|April 24, 2023
Pattern Completion and Rate Remapping in Retrosplenial CortexZaneta Navratilova, Dhruba Banerjee, Fjolla Muqolli, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentNathaniel Guanzon, Yessenia Gallegos, Chase Redd, et al.
Journal of Hematology & Oncology|November 30, 2012
A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomideEunice S Wang, Roger M Lyons, Richard A Larson, et al.
Elife|February 22, 2022
TREM2 regulates purinergic receptor-mediated calcium signaling and motility in human iPSC-derived microgliaAmit Jairaman, Amanda McQuade, Alberto Granzotto, et al.
Annals of Clinical and Translational Neurology|January 12, 2026
Fluid and Neuroimaging Biomarkers in Microgliopathy Colony-Stimulating Factor-1 Receptor-Related DisordersTomasz Chmiela, Madison Reeves, Karen Jansen-West, et al.
Cancer Immunology, Immunotherapy : CII|March 2, 2024
A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancerGerald S Falchook, James Reeves, Sunil Gandhi, et al.
Neuron|June 19, 2024
Therapeutic potential of human microglia transplantation in a chimeric model of CSF1R-related leukoencephalopathyJean Paul Chadarevian, Jonathan Hasselmann, Alina Lahian, et al.
JAMA Oncology|September 1, 2022
Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical TrialNizar M Tannir, Neeraj Agarwal, Camillo Porta, et al.
Pageof 2